Literature DB >> 30903574

Exosomal packaging of trans-activation response element (TAR) RNA by HIV-1 infected cells: a pro-malignancy message delivery to cancer cells.

Nilesh Kumar Sharma1.   

Abstract

Driven by the heterogeneous and complex nature of HIV-1 infection and tumors, the possibilities of viable cross-talk are facilitated by the intra-cellular and inter-cellular signaling regimens. There are evidences that support the clear role of exosomes containing TAR RNAs that are secreted by HIV-1 infected cells and these TAR RNA brings pro-growth and pro-survival effects upon cancer cells. Recently, the regulatory role of TAR RNAs in the intra-cellular signaling network is shown that augments cancer cells to achieve tremendous progression and malignancy. In this paper, author highlights the role of HIV-1 infected cells secreted exosomes containing TAR RNA in tumor hallmarks. Further, this paper provides future insights on new classes of cancer therapeutics centered on disrupting exosomes and TAR RNA.

Entities:  

Keywords:  Exosome; HIV-1; Neoplasm; Receptor; Signaling; T Cell; TAR RNA

Mesh:

Substances:

Year:  2019        PMID: 30903574     DOI: 10.1007/s11033-019-04770-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

1.  Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR.

Authors:  M Benkirane; C Neuveut; R F Chun; S M Smith; C E Samuel; A Gatignol; K T Jeang
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

2.  Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR.

Authors:  S H Kim; A P Forman; M B Mathews; S Gunnery
Journal:  Oncogene       Date:  2000-06-22       Impact factor: 9.867

3.  CRISPR-Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV-host factor interactions.

Authors:  Judd F Hultquist; Joseph Hiatt; Kathrin Schumann; Michael J McGregor; Theodore L Roth; Paige Haas; Jennifer A Doudna; Alexander Marson; Nevan J Krogan
Journal:  Nat Protoc       Date:  2019-01       Impact factor: 13.491

Review 4.  The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].

Authors:  Vignesh Sundararajan; Fazlul H Sarkar; Thamil Selvee Ramasamy
Journal:  Cell Oncol (Dordr)       Date:  2018-04-17       Impact factor: 6.730

5.  Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients.

Authors:  Stoyan Naidenov Bichev; Dora Marinova Marinova; Yanina Georgieva Slavova; Alexey Slavkov Savov
Journal:  Cell Oncol (Dordr)       Date:  2014-12-23       Impact factor: 6.730

6.  Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer.

Authors:  Yu Zhao; Liguo Wang; Shancheng Ren; Lan Wang; Patrick R Blackburn; Melissa S McNulty; Xu Gao; Meng Qiao; Robert L Vessella; Manish Kohli; Jun Zhang; R Jeffrey Karnes; Donald J Tindall; Youngsoo Kim; Robert MacLeod; Stephen C Ekker; Tiebang Kang; Yinghao Sun; Haojie Huang
Journal:  Cell Rep       Date:  2016-04-07       Impact factor: 9.423

Review 7.  CRISPR-Cas9 for cancer therapy: Opportunities and challenges.

Authors:  Minjiang Chen; Aiwu Mao; Min Xu; Qiaoyou Weng; Jianting Mao; Jiansong Ji
Journal:  Cancer Lett       Date:  2019-01-23       Impact factor: 8.679

8.  Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA.

Authors:  Aarthi Narayanan; Sergey Iordanskiy; Ravi Das; Rachel Van Duyne; Steven Santos; Elizabeth Jaworski; Irene Guendel; Gavin Sampey; Elizabeth Dalby; Maria Iglesias-Ussel; Anastas Popratiloff; Ramin Hakami; Kylene Kehn-Hall; Mary Young; Caroline Subra; Caroline Gilbert; Charles Bailey; Fabio Romerio; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2013-05-09       Impact factor: 5.157

Review 9.  CRISPR/Cas9-mediated noncoding RNA editing in human cancers.

Authors:  Jie Yang; Xiaodan Meng; Jinchang Pan; Nan Jiang; Chengwei Zhou; Zhenhua Wu; Zhaohui Gong
Journal:  RNA Biol       Date:  2017-11-09       Impact factor: 4.652

10.  In silico Analyses of Subtype Specific HIV-1 Tat-TAR RNA Interaction Reveals the Structural Determinants for Viral Activity.

Authors:  Larance Ronsard; Tripti Rai; Devesh Rai; Vishnampettai G Ramachandran; Akhil C Banerjea
Journal:  Front Microbiol       Date:  2017-08-08       Impact factor: 5.640

View more
  3 in total

Review 1.  Experimental Systems for Measuring HIV Latency and Reactivation.

Authors:  Koh Fujinaga; Daniele C Cary
Journal:  Viruses       Date:  2020-11-09       Impact factor: 5.048

Review 2.  Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin?

Authors:  Sharon de Toledo Martins; Lysangela Ronalte Alves
Journal:  Front Cell Infect Microbiol       Date:  2020-12-01       Impact factor: 5.293

Review 3.  Effects of Exosomal Viral Components on the Tumor Microenvironment.

Authors:  Jing Li; Yan Zhang; Bing Luo
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.